Immunolog

The University of Gothenburg tackles society’s challenges with diverse knowledge. 56 000 students and 6 600 employees make the university a large and inspiring place to work and study. Strong research and attractive study programmes attract researchers and students from around the world. With new knowledge and new perspectives, the University contributes to a better future.  Subject area  Tumor immunity Subject area description  The immune system is important to fight tumors, and this ability can be further improved by immunotherapy. Our research group studies immunity to tumors in the large intestine and investigates how we can harness components of the immune response to enhance anti-tumor immunity further. More specifically, we are interested in unconventional T cells, a group of T cells which in humans comprise mainly gd T cells and mucosa-associated invariant T (MAIT) cells. We focus primarily on their migration into tumors, their different effector functions, their contribution to anti-tumor immunity and if these features can be used for immunotherapy. Duties  The employment primarily includes independent research on the role of unconventional T cells in tumor immunity, more precisely planning, execution and analysis of experiment aimed at elucidating cytotoxic mechanisms. Presentation of results in scientific journals and in conferences. Participation in the research group’s collective efforts to isolate cells from tissue samples, responsibility for selected pieces of equipment, and participation in internal meetings and discussions. Supervision of students. Eligibility  The eligibility criteria for employing teaching staff are set out in Chapter 4 of the Higher Education Ordinance and in the Appointment Procedure for Teaching Posts at the University of Gothenburg.  To be eligible for appointment as a postdoc, the applicant is required to have a doctoral degree, a doctoral degree in art or a foreign degree that is deemed to be equivalent to a doctoral degree. This eligibility requirement must be met before the employment decision is made.  In the first instance, those who have completed their degree no more than three years prior to the end of the application period shall be considered. Those who have completed their degree more than three years prior to the end of the application period may also be considered in the first instance if special grounds exist. Special grounds relate to leave of absence due to illness, parental leave, commissions of trust within union organisations, service within the defence services or other similar circumstances, as well as clinical service or service/assignment relevant to the subject area.   Assessment criteria  A PhD in immunology is a requirement to be considered for the employment. Experience of successful planning and execution of independent research in the field of immunology, compilation and interpretation of scientific studies, and writing of scientific articles is of major importance. Experience in flow cytometric analyses is a strong merit, as well as experience in methods to isolate and culture human primary cells from tissues. In addition, experience in bioinformatic analyses and advanced microscopy is also advantageous. Furthermore, organizational skills, accuracy, and a good ability to cooperate with different groups of staff is required. Regulations for the evaluation of qualifications for academic positions are given in Chapter 4, Section 3 - 4 of the Higher Education Ordinance. Employment  The employment is full time and temporary, two years with the possibility of one year's extension, with placement at the Institute of Biomedicine. First day of employment as agreed. Contact information  If you have any questions about the position, please contact: Professor Marianne Quiding Järbrink https://www.gu.se/en/research/marianne-quiding-jarbrink Phone: 031-786 6215 Email: [email protected] Unions  Union representatives at the University of Gothenburg can be found here: https://www.gu.se/om-universitetet/jobba-hos-oss/hjalp-for-sokande  Application  Submit your application via the University of Gothenburg’s recruitment portal by clicking the “Apply” button. It is your responsibility to ensure that the application is complete as per the vacancy notice, and that the University receives it by the final application deadline.   The application should contain: • A cover letter giving a brief description of previous research experience, and a motivation to why you are applying • A detailed CV including a list of publications • Contact details of two references • Proof of completed PhD Applications must be received by: 2025-01-31  Information for International Applicants  Choosing a career in a foreign country is a big step. Thus, to give you a general idea of what we and Gothenburg have to offer in terms of benefits and life in general for you and your family/spouse/partner please visit:  https://www.gu.se/en/about-the-university/welcome-services  https://www.movetogothenburg.com/  The University works actively to achieve a working environment with equal conditions, and values the qualities that diversity brings to its operations. Salaries are set individually at the University. In accordance with the National Archives of Sweden’s regulations, the University must archive application documents for two years after the appointment is filled. If you request that your documents are returned, they will be returned to you once the two years have passed. Otherwise, they will be destroyed. In connection to this recruitment, we have already decided which recruitment channels we should use. We therefore decline further contact with vendors, recruitment and staffing companies.

12 Months Early Respiratory & Immunology - In Vivo – Student Work Placement About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical business and its innovative medicines are used by millions of patients worldwide. AstraZeneca has long been an advocate of student work placement training. AstraZeneca considers its responsibility to help promising scientists develop into the researchers of the future, by immersing them in a world of practical science. This is achieved by aligning each student with a research team working on cutting-edge drug discovery projects. You will feel trusted and empowered to take on new challenges, but with all the help and guidance you need to succeed. Introduction to role The Early Respiratory & Immunology In Vivo Student Work Placement Program offers a unique 12-month opportunity to dive into the world of innovative drug discovery. At AstraZeneca, you will engage in meaningful work that pushes the boundaries of science to deliver life-changing medicines. This placement will help you develop essential skills, knowledge, and a professional network, all while working alongside passionate and curious individuals in a truly collaborative and global team. Accountabilities We offer 12-month placements at AstraZeneca’s Gothenburg site in Sweden for students at Swedish institutions. The role focuses on characterising immune cell populations in colon samples from various in vivo models of IBD, aiming to understand immune response kinetics comprehensively. You will be involved in developing multiplex panels for histology assessment, conducting staining, and performing automated image analysis under the supervision of an experienced scientist. The techniques and markers developed can also be applied to study respiratory diseases, providing a versatile approach to understanding immune responses in diverse tissue contexts. You will work in well-equipped lab facilities with state-of-the-art histology equipment and image analysis software, gaining hands-on experience and insight into important areas of the pre-clinical research process. Essential Skills/Experience BSc or MSc or equivalent students in any Bioscience, Immunology or aligned course at a Swedish University. You must have completed at least two years of your university education at the time of starting the placement and be returning to complete your studies after this opportunity ends. Performing at a high level, with the potential to achieve a pass with distinction. Applicants must have the eligibility to work in Sweden for 12 months from September 2025 without the need for additional work permits. Students will be expected to take a study break from their education to participate in the programme; this will need to be arranged by the student at their institution. Please ensure that you receive approval to take a study break from your university. Proactive approach to experimental design and execution. Desirable Skills/Experience Basic knowledge in tissue processing, histological staining techniques, immunohistochemistry, and image analysis. AstraZeneca is committed to fostering an inclusive and supportive international team. As a placement student, you will have access to a vast network of support, empowering you to take on new challenges with confidence. Our supervisors are dedicated to providing guidance and support, ensuring you build your skills and capabilities. You will be welcomed into an environment where curiosity is encouraged, questions are valued, and knowledge is shared. This collaborative atmosphere allows you to grow as a professional while contributing to meaningful projects that have real patient impact. Additional Information: Applications are now open until January 2025, with interviews to take place in March 2025. Start date 1st September 2025. Applications must be submitted in English. After you submit your application, you will receive a link to complete your application where you will be invited to answer questions about your motivation for this placement and upload your English CV, transcripts if available and certificate of registration. This internship is a collaboration between AstraZeneca and Kelly Services. The employment relationship is with Kelly Services partner, Poolia AB. Please inform us if you require adjustment support when contacted to schedule an interview – necessary adjustments can be made for assessment centers. Ready to make a difference? Apply now and take the first step towards an exciting career with AstraZeneca!